Lin S K, Chang W H, Chung M C, Lam Y W, Jann M W
Taipei City Psychiatric Center, Taiwan, Republic of China.
J Clin Pharmacol. 1994 Apr;34(4):318-24. doi: 10.1002/j.1552-4604.1994.tb02000.x.
The disposition of the atypical clozapine and its desmethyl metabolite were evaluated in fourteen male chronic patients. A single 100 mg dose of clozapine was administered and blood sampling performed over the following 72 hours. The mean (SD) oral clearance and half-life of clozapine were 55.4 (29.7) L/hr and 13.7 (9.9) hours, respectively. The mean (SD) AUC for clozapine and desmethylclozapine was 2389.9 (1406) and 751.1 (622.9) ng.hr/mL, respectively. The elimination of the metabolite is rate limited by its formation from cloza-pine. A wide interpatient variability in clozapine and desmethylclozapine pharmacokinetics was observed.
在14名男性慢性患者中评估了非典型抗精神病药物氯氮平及其去甲基代谢物的处置情况。给予单次100mg剂量的氯氮平,并在接下来的72小时内进行血样采集。氯氮平的平均(标准差)口服清除率和半衰期分别为55.4(29.7)L/小时和13.7(9.9)小时。氯氮平和去甲基氯氮平的平均(标准差)AUC分别为2389.9(1406)和751.1(622.9)ng·小时/mL。代谢物的消除受其从氯氮平形成的速率限制。观察到氯氮平和去甲基氯氮平的药代动力学在患者间存在很大差异。